Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
September 23, 2016 at 13:15 PM EDT
Once again, acquisitions and deals were in focus in the pharma sector with Allergan announcing a couple of back-to-back deals including one worth up to $1.695 billion.
